The impact of ABO and RhD blood types on Babesia microti infection
Open Access
- 25 January 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 17 (1) , e0011060
Abstract
Background: Babesiosis is an emerging infectious disease caused by intraerythrocyticBabesiaparasites that can cause severe disease and death. While blood type is known to affect the mortality ofPlasmodium falciparummalaria patients, associations between red blood cell (RBC) antigens andBabesia microtiinfection and disease severity are lacking.Methods: We evaluated RhD and ABO blood types ofBabesia-infected (18S rRNA reactive) blood donors in 10 endemic states in the Northeastern and northern Midwestern United States. We also assessed possible associations between RhD and ABO blood types and disease severity among hospitalized babesiosis patients in Connecticut.Results: A total of 768Babesia-infected blood donors were analyzed, of which 750 (97.7%) had detectableB.microti-specific antibodies.B.microti-infected blood donors were more likely to be RhD- (OR of 1.22, p-value 0.024) than RhD+ donors. Hospitalized RhD- babesiosis patients were more likely than RhD+ patients to have high peak parasitemia (p-value 0.017), which is a marker for disease severity. No differences in RhD+ blood type were noted between residents of the Northeast (OR of 0.82, p-value 0.033) and the Midwest (OR of 0.74, p-value 0.23). Overall, ABO blood type was not associated with blood donorB.microtiinfection, however,B.microti-infected donors in Maine and New Jersey were more likely to be blood type B compared to non-type B (OR 2.49 [p = 0.008] and 2.07 [p = 0.009], respectively), while infected donors from Pennsylvania were less likely to be type B compared to non-type B (OR 0.32 [p = 0.02]).Conclusions: People expressing RhD antigen may have a decreased risk ofB.microtiinfection and babesiosis severity. The association of B antigen withB.microtiinfection is less clear because the antigen appeared to be less prevalent in infected Pennsylvania blood donors but more prevalent in Maine and New Jersey infected donors. Future studies should quantify associations betweenB.microtigenotypes, RBC antigens, and the frequency and severity ofB.microtiinfection to increase our understanding of humanBabesiapathogenesis and improve antibody, vaccine, and RBC exchange transfusion strategies.Keywords
Funding Information
- Llura A. Gund Laboratory for Vector-borne Diseases
- Gordon and Llura Gund Foundation
- NIH (K12HL141953)
This publication has 40 references indexed in Scilit:
- Assessing ABO/Rh Blood Group Frequency and Association with Asymptomatic Malaria among Blood Donors Attending Arba Minch Blood Bank, South EthiopiaMalaria Research and Treatment, 2016
- Human BabesiosisNew England Journal of Medicine, 2012
- Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparumNature, 2011
- Structure of a Plasmodium falciparum PfEMP1 rosetting domain reveals a role for the N-terminal segment in heparin-mediated rosette inhibitionProceedings of the National Academy of Sciences, 2011
- Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosettingProceedings of the National Academy of Sciences, 2007
- The ABO blood group system and Plasmodium falciparum malariaBlood, 2007
- Babesia divergensandPlasmodium falciparumUse Common Receptors, Glycophorins A and B, To Invade the Human Red Blood CellInfection and Immunity, 2005
- Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathwaysProceedings of the National Academy of Sciences, 2003
- Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populationsNature Medicine, 2002
- Human Babesiosis in New York StateArchives of internal medicine (1960), 1998